CD19 and depressive symptom measurement: Also, BD patients in depression had significantly higher percentage of CD19+ cells compared to healthy control (5,13 ± 0,39 vs. 3,52 ± 0,26, p = 0,031415, ANOVA with post-hoc Tukey test, Fig. 1B).